» Articles » PMID: 16741880

Human Cytomegalovirus Infection is Associated with Increased Proportions of NK Cells That Express the CD94/NKG2C Receptor in Aviremic HIV-1-positive Patients

Overview
Journal J Infect Dis
Date 2006 Jun 3
PMID 16741880
Citations 125
Authors
Affiliations
Soon will be listed here.
Abstract

In healthy blood donors, serological positivity for human cytomegalovirus (HCMV) is associated with an increased proportion of NK cells bearing the CD94/NKG2C NK cell receptor (NKR). The expression of the activating CD94/NKG2C NKR and of the inhibitory CD94/NKG2A NKR was studied in a cohort of 45 aviremic human immunodeficiency virus type 1 (HIV-1)-positive patients receiving highly active antiretroviral therapy. The proportions of NKG2C+ NK cells were significantly increased in HIV-1-positive patients (mean +/- SD, 25.9% +/- 23.0%), compared with those in 31 healthy individuals (mean +/- SD, 16.1% +/- 20.7%). Yet, the association vanished when HCMV serological status was considered in a multivariate regression model. These results support the conclusion that changes in the NKR repertoire in HIV1-positive patients are related to a concomitant HCMV infection.

Citing Articles

Emerging Insights into Memory Natural Killer Cells and Clinical Applications.

Kokici J, Preechanukul A, Arellano-Ballestero H, Gorou F, Peppa D Viruses. 2024; 16(11).

PMID: 39599860 PMC: 11599065. DOI: 10.3390/v16111746.


NKG2C Sequence Polymorphism Modulates the Expansion of Adaptive NK Cells in Response to Human CMV.

Asenjo J, Moraru M, Al-Akioui-Sanz K, Altadill M, Muntasell A, Lopez-Botet M HLA. 2024; 104(5):e15764.

PMID: 39581700 PMC: 11586157. DOI: 10.1111/tan.15764.


Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxis.

Zamora D, Dasgupta S, Stevens-Ayers T, Edmison B, Winston D, Razonable R JCI Insight. 2024; 9(18).

PMID: 39099206 PMC: 11457861. DOI: 10.1172/jci.insight.180115.


Natural killer cells- from innate cells to the discovery of adaptability.

Basilio-Queiros D, Mischak-Weissinger E Front Immunol. 2023; 14:1172437.

PMID: 37275911 PMC: 10232812. DOI: 10.3389/fimmu.2023.1172437.


Editorial: Natural killer cell plasticity and diversity in antiviral immunity.

Krebs P, Peng H, Duhan V Front Immunol. 2023; 14:1175111.

PMID: 36999011 PMC: 10043422. DOI: 10.3389/fimmu.2023.1175111.